Factors associated with decompression and strabismus surgery in thyroid eye disease

Annals of the Academy of Medicine Singapore

Volumn 34, Issue 2, 2005, Pages 154-157

  Looi, Audrey L G ^a   Luu, C D ^b   Wong, T Y ^a,b,c   Seah, L L ^a   Rootman, J ^a,d  

^a SINGAPORE NATIONAL EYE CENTRE   (Singapore)

^b SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^c NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Risk factors; Thyroid eye disease

Indexed keywords

ANTITHYROID AGENT; RADIOACTIVE IODINE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DECOMPRESSION SURGERY; DIPLOPIA; ENDOCRINE OPHTHALMOPATHY; EXOPHTHALMOS; EYE DISEASE; FEMALE; HUMAN; HYPERTHYROIDISM; MALE; OPTIC NERVE DISEASE; PROGNOSIS; REGRESSION ANALYSIS; STRABISMUS; STRABISMUS SURGERY; THYROID DISEASE; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 17444415270     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Bartalena L, Marcocci C, Pinchera A. Graves' ophthalmopathy: a preventable disease? Eur J Endocrinol 2002;146:457-61.
2. Kendler DL, Lippa J, Rootman J. The initial characteristics of Graves' orbitopathy vary with age and sex. Arch Ophthalmol 1993;111:197-201.
3. Perros P, Crombie AL, Matthews JN, Kendall-Taylor P. Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combined thyroid-eye clinic. Clin Endocrinol 1993;38:367-72.
4. Tellez M, Cooper J, Edmonds C. Graves' ophthalmopathy in relation to cigarette smoking and ethnic origin. Clin Endocrinol 1992;36:291-4.
5. Bartalena L, Bogazzi F, Tanda ML, Manetti L, Dell'Unto E, Martino E. Cigarette smoking and the thyroid. Eur J Endocrinol 1995;133:507-12.
6. Bartalena L, Marcocci C, Tanda ML, Manetti L, Dell'Unto E, Bartolomei MP, et al. Cigarette smoking and treatment outcomes in Graves ophthalmopathy. Ann Intern Med 1998;129:632-5.
7. Mann K. Risk of smoking in thyroid-associated orbitopathy. Exp Clin Endocrinol Diabetes 1999;107(Suppl):S164-S167.
8. Prummel MF, Wiersinga WM, Mourits MP, Koornneef L, Berghout A, van der Gaag R. Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy. Arch Intern Med 1990;150:1098-101.
9. Bartalena L, Marcocci C, Bogazzi F, Manetti L, Tanda ML, Dell'Unto E, et al. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med 1998;338:73-8.
10. 131I and thyroid-associated ophthalmopathy. Eur J Endocrinol 2000;143:155-60.
11. Kim JM, LaBree L, Levin L, Feldon SE. The relation of Graves' ophthalmology to circulating thyroid hormone status. Br J Ophthalmol 2004;88:72-4.
12. Bartalena L, Pinchera A, Marcocci C. Management of Graves' ophthalmopathy: reality and perspectives. Endocr Rev 2000;21:168-99.
13. Rootman J. Graves' orbitopathy. In: Rootman J. Diseases of the Orbit. A Multidisciplinary Approach, 2nd ed. Philadelphia: J.B. Lippincott Co, 1988:243.